Tadashi Kondo

Chief

National Cancer Center Research Institute

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Tadashi Kondo is the Chief at the National Cancer Center Research Institute in Japan. His research areas focus on the identification of cancer-associated proteins, pharmacokinomic profiling, and the establishment of novel patient-derived cell lines for various types of cancers. His recent articles highlight significant contributions to understanding colorectal cancer and ependymoma formation among other malignancies.

Articles (10)

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (1)

Syuzo Kaneko

Laboratory Head

National Cancer Center

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tadashi Kondo

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Identification of Cancer-Associated Proteins in Colorectal Cancer Using Mass Spectrometry

Pharmacokinomic Profiling Using Patient-Derived Cell Lines Predicts Sensitivity to Imatinib in Dermatofibrosarcoma Protuberans

Correction: Noguchi et al. Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei. <i>J. Pers. Med.</i> 2022, <i>12</i>, 258

Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei

Establishment and Characterization of NCC-MFS5-C1: A Novel Patient-Derived Cell Line of Myxofibrosarcoma

Establishment and characterization of NCC-MPNST6-C1: a novel patient-derived cell line of malignant peripheral nerve sheath tumors

Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma

Establishment and characterization of the NCC-GCTB4-C1 cell line: a novel patient-derived cell line from giant cell tumor of bone

Prognostic Role for Primary Tumor Location in Patients with Colorectal Liver Metastases

C11orf95-RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation

Collaborators (1)

Syuzo Kaneko

Make your next move.